United Kingdom · 
Who invested in Sitryx Therapeutics?
Sitryx Therapeutics's investors include Sofinnova Partners, Eli Lilly, Oxford Science Enterprises, SV Health Investors and Longwood Fund.
United Kingdom · Series A startup
Who invested in Sitryx Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$39Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $39MSept 2023
- Investors
- 5
The rounds
- Sept 2023Series A$39M
Source recorded
Everyone who backed them
SV Health InvestorsVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Sitryx Therapeutics
How much has Sitryx Therapeutics raised?
Sitryx Therapeutics has raised $39M across 1 round since 2023.
When did Sitryx Therapeutics last raise?
Sitryx Therapeutics's most recent round was a Series A of $39M in Sept 2023.
What was Sitryx Therapeutics's biggest round?
Its most recent round, $39M in Sept 2023, is also its largest on record.
Who backed Sitryx Therapeutics first?
Sitryx Therapeutics's first round on record, in Sept 2023, was backed by Sofinnova Partners, Eli Lilly and Oxford Science Enterprises and 2 others.
What stage is Sitryx Therapeutics at?
Sitryx Therapeutics's latest named round is a Series A, in Sept 2023.
Where is Sitryx Therapeutics based?
Sitryx Therapeutics is based in the United Kingdom.
Companies like Sitryx Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.